恒指跌幅扩至逾600点 美团/舜宇/药明生物吐逾6%-7% 惟中银逆市续升逾2%
美国2月ISM服务业指数及2月ADP私企就业职位增速长缓速度远超预期,加上债息回升,投资者继续沽售市值较高科技股,美股在科技股主导连跌两天,尤其是纳指续挫2.7%,标普续跌1.3%;但金融、能源及部分工业股造好,支持道指仅反覆续吐0.4%。不过,美股期货全面续跌0.2%-0.5%,纳指期货续跑输报12,615。亚太区主要股市全面回吐,其中菲股、澳股、台股、韩股及日经跌1.1%-1.8%;上证及深成跌幅扩至1.4%及2.6%,分别报3,527及14,542。
本港今年1月零售额按年跌幅意外进一步略扩至13.6%(前值续降13.2%),为半年来最伤,且已连跌24个月,市场原预期降幅收窄至11.4%。
憧憬人行「降准」,恒指继昨天在金融板块发力飙升带动急弹784点或2.7%重越20天线後,今早在重磅股腾讯(00700.HK)、美团(03690.HK)及银娱(00027.HK)低开逾3%拖累低开354点或1.2%报29,525,跌幅持续扩至627点或2.1%,报29,253。
蓝筹股普遍下跌,药明生物(02269.HK)挫7.5%报94.75元为最伤蓝筹;其次为舜宇(02382.HK)及美团分别回吐6.8%及6.5%,分别低见190元及344.6元。腾讯回吐3.2%曾低见696元,股价失守10天线(702元)。
港交所(00388.HK)、百威亚太(01876.HK)、小米(01810.HK)、全年多赚30%末期息年增41%创科(00669.HK)、安踏(02020.HK)及银娱(00027.HK)及吉利汽车(00175.HK)吐逾3%-4.5%,前者失守50天线(487.4元),曾低见480.8元。不过,恒生(00011.HK)、港铁(00066.HK)及中银(02388.HK)逆升0.3%-2.3%,後者最高见27.4元,现造26.95元,续升2.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.